Guerir Pharmaceuticals Private Limited, a active private limited company, was established on 01 December 2016 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U52399DL2016PTC308768. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Avinash Singh (Director), Amit Singh (Director). Past directors included Nagendra Singh. It holds ₹3.00 M open charges and ₹1.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D-246, Office No 301-302, 3Rd Floor, Balaji Chambe Gali No-10, Vikas Marg, Laxmi Nagar, Delhi, Delhi, 110092.
U52399DL2016PTC308768
308768
01 December 2016
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Guerir Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avinash Singh | Director | 01 Dec 2016 | Current |
| Amit Singh | Director | 29 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Guerir Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.26% increase. The company also saw a slight improvement in profitability, with a 3.45% increase in profit. The company's net worth Soared by an impressive increase of 95.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Guerir Pharmaceuticals had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹1,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2017 | Others | ₹3.00 M | Open |
| 07 Feb 2017 | Indian Overseas Bank | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Guerir Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Guerir Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Guerir Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Guerir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Guerir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
Amit Singh was appointed as a Director was appointed as a Director on 29 Sep 2018 & has been associated with this company since 7 years 3 months . was recorded as a recent event.
Progress on A charge registered on 07 Feb 2017 via Charge ID 100082845 with Indian Overseas Bank was fully satisfied on 19 Sep 2017. was documented.
A charge with Others amounted to Rs. 3.00 M with Charge ID 100123981 was registered on 12 Sep 2017. was recorded as a recent event.
The activity A charge with Indian Overseas Bank amounted to Rs. 1.50 M with Charge ID 100082845 was registered on 07 Feb 2017. was completed.
The CIN of Guerir Pharmaceuticals Private Limited is U52399DL2016PTC308768.
Guerir Pharmaceuticals Private Limited is headquartered at D-246, Office No 301-302, 3Rd Floor, Balaji Chambe Gali No-10, Vikas Marg, Laxmi Nagar, Delhi, Delhi, 110092.
Guerir Pharmaceuticals Private Limited was incorporated on 01 December 2016.
The current directors of Guerir Pharmaceuticals Private Limited are
The primary industry of Guerir Pharmaceuticals Private Limited is Manufacturing.
Guerir Pharmaceuticals Private Limited is unlisted.
The authorized capital of Guerir Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Guerir Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX